May #35 : Mother's Little Helpers - by Scott Hess

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Just His Imagination

Down On the Pharm

From Unsafe to Ill

Power Plants

Take a Letter, Shalala

Sherri on Top

Jibe Talk

AIDS and the Single Girl

Lazarus: Love Among the Ruins

Survey: A Council Resigned

Plant Primer

S.O.S.

Garden Variety

Spit Tune

Life: Good Pill Hunting

Last Laugh: Impossible Dream

What's The Point?

Read This: Heroic Measures

Number's Up

Mother's Little Helpers

A Yale Tale

The Big Sleep

Bearback

Say What

More Life: Even Tough Guys Get HIV

Tribute: My Brother, My Self

HIV Naysayers Find Their Achilles' HEAL



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

May 1998

Mother's Little Helpers

by Scott Hess

Triple cocktails for two

Add another chapter to What to Expect When You're Expecting. AZT monotherapy -- for women who can get it -- has cut the rate of mother-to-infant HIV transmission to eight percent. Now, triple-drug therapy may reduce the risk of mom-to-infant HIV transmission even further, according to a small San Francisco-based study.

A program initiated in 1996 by Dr. Karen Beckerman of the Bay Area Perinatal AIDS Center (BAPAC) offered moms-to-be antiretroviral combos (such as AZT/3TC/ Viracept), instead of the standard AZT monotherapy. Of 58 babes born to moms on the cocktail since then, not one has tested positive; all will be monitored to age 2. "Our goal is to get our moms to their kids' high-school graduations," Beckerman said.

While some women started the program already on triple therapy, for the antiretroviral virgins, "we usually recommend that they wait until 12 to 14 weeks of pregnancy to start antiretrovirals," said Beckerman, adding that those doing well on an existing therapy are encouraged to stay with it. "We also counsel our mothers that there is nothing known about the drugs' effects on the developing fetus, so the decision is theirs. Adhering to drug regimens postpartum can be "extremely difficult," so Beckerman advises a carefully negotiated plan. She expects more women to opt for triple therapy as more drug safety and efficacy info becomes available. "There's a theoretical risk for the babies, but HIV-infected people need to have the option to be on anti-HIV drugs," she said. "It could be dangerous for moms not to take the drugs."




[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    slimcuteguy
    Asheville
    North Carolina


    TaintedloveDC
    Washington
    DC


    robert12
    Queens
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.